Literature DB >> 9558372

The P2X1 receptor, an adenosine triphosphate-gated cation channel, is expressed in human platelets but not in human blood leukocytes.

E E Clifford1, K Parker, B D Humphreys, S B Kertesy, G R Dubyak.   

Abstract

Extracellular adenosine triphosphate (ATP) and adenosine diphosphate (ADP) activate multiple types of P2-nucleotide receptors expressed in platelets or leukocytes. Electrophysiological and biochemical studies have indicated expression of the P2X1 receptor, an ATP-gated cation channel, in human and rat platelets, rat basophilic leukemia (RBL) cells, and phorbol myristate acetate (PMA)-differentiated HL-60 myeloid cells. Although these findings suggest that P2X1 receptors are present in both blood leukocytes and blood platelets, the relative levels of P2X1 receptor expression and function in human blood leukocytes and platelets have not been directly characterized. On the basis of both immunoblot analysis and functional assays of P2X1 receptor-mediated ionic fluxes, we report that there is significant expression of P2X1 receptors in human platelets, but not in neutrophils, monocytes, or blood lymphocytes. Thus, unlike platelets and myeloid progenitor cell lines, fully differentiated human blood leukocytes do not express functionally significant numbers of P2X1 receptors, suggesting the downregulation of P2X1 receptor gene expression during the differentiation of phagocytic leukocytes. By contrast, P2X1 receptor expression is strongly maintained during megakaryocytic differentiation and platelet release. Immunoblot analysis indicated that the platelet P2X1 receptor migrates as an approximately 60-kD protein during SDS-electrophoresis under reducing or nonreducing conditions. Treatment of platelet membranes with endoglycosidase-F causes the P2X1 receptor band to migrate as a 46-kD protein, verifying the highly glycosylated nature of the mature receptor protein. Additional studies of nucleotide-induced changes in Ca2+ influx/mobilization demonstrated that the platelet P2X1 receptors are pharmacologically distinct from the well-characterized ADP receptors of these cells. This finding suggests a unique role for these ATP-gated ion channels during hemostasis or thrombosis.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9558372

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  18 in total

1.  P2X1 expressed on polymorphonuclear neutrophils and platelets is required for thrombosis in mice.

Authors:  Roxane Darbousset; Céline Delierneux; Soraya Mezouar; Alexandre Hego; Christelle Lecut; Isabelle Guillaumat; Markus A Riederer; Richard J Evans; Françoise Dignat-George; Laurence Panicot-Dubois; Cécile Oury; Christophe Dubois
Journal:  Blood       Date:  2014-08-22       Impact factor: 22.113

2.  Modulation of ATP-gated non-selective cation channel (P2X1 receptor) activation and desensitization by the actin cytoskeleton.

Authors:  K E Parker
Journal:  J Physiol       Date:  1998-07-01       Impact factor: 5.182

3.  Vascular smooth muscle cells from small human omental arteries express P2X1 and P2X4 receptor subunits.

Authors:  Claire M Nichols; Oleksandr V Povstyan; Anthony P Albert; Dmitry V Gordienko; Omar Khan; Georgios Vasilikostas; Teck K Khong; Andrew Wan; Marcus Reddy; Maksym I Harhun
Journal:  Purinergic Signal       Date:  2014-05-22       Impact factor: 3.765

Review 4.  Identification, characterization, and inhibition of the platelet ADP receptors.

Authors:  C Gachet
Journal:  Int J Hematol       Date:  2001-12       Impact factor: 2.490

5.  A study of P2X1 receptor function in murine megakaryocytes and human platelets reveals synergy with P2Y receptors.

Authors:  Catherine Vial; Michael G Rolf; Martyn P Mahaut-Smith; Richard J Evans
Journal:  Br J Pharmacol       Date:  2002-01       Impact factor: 8.739

6.  Defective platelet aggregation and increased resistance to thrombosis in purinergic P2Y(1) receptor-null mice.

Authors:  C Léon; B Hechler; M Freund; A Eckly; C Vial; P Ohlmann; A Dierich; M LeMeur; J P Cazenave; C Gachet
Journal:  J Clin Invest       Date:  1999-12       Impact factor: 14.808

7.  Purinergic system ecto-enzymes participate in the thromboregulation of patients with indeterminate form of Chagas disease.

Authors:  Viviane do Carmo Gonçalves Souza; Karine B Schlemmer; Cristiano B Noal; Jeandre A S Jaques; Margarete D Bagatini; Victor C Pimentel; Luiz Felipe D Carli; Cláudio A M Leal; Juliana Fleck; Maria B Moretto; Maria R C Schetinger; Daniela B R Leal
Journal:  Purinergic Signal       Date:  2012-07-01       Impact factor: 3.765

8.  Alpha-hemolysin from Escherichia coli uses endogenous amplification through P2X receptor activation to induce hemolysis.

Authors:  Marianne Skals; Niklas R Jorgensen; Jens Leipziger; Helle A Praetorius
Journal:  Proc Natl Acad Sci U S A       Date:  2009-02-18       Impact factor: 11.205

Review 9.  Blood cells: an historical account of the roles of purinergic signalling.

Authors:  Geoffrey Burnstock
Journal:  Purinergic Signal       Date:  2015-08-11       Impact factor: 3.765

Review 10.  Involvement of P2 receptors in hematopoiesis and hematopoietic disorders, and as pharmacological targets.

Authors:  Kelly Juliana Filippin; Kamylla F S de Souza; Roberto Theodoro de Araujo Júnior; Heron Fernandes Vieira Torquato; Dhébora Albuquerque Dias; Eduardo Benedetti Parisotto; Alice Teixeira Ferreira; Edgar J Paredes-Gamero
Journal:  Purinergic Signal       Date:  2019-12-20       Impact factor: 3.765

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.